Dobutamine

Back to search

Molecule Structure

Scientific Name

Dobutamine

Description of the Drug

Dobutamine is a beta-1 agonist used to treat cardiac decompensation in patients with organic heart disease or from cardiac surgery.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00841

Brand Name(s)

Not Available

Company Owner(s)

Luitpold Pharmaceuticals Inc, Baxter Healthcare Corp Anesthesia And Critical Care, Hospira Inc, Watson Laboratories Inc, Teligent Pharma Inc, Teva Parenteral Medicines Inc, Eli Lilly And Co, Dr Reddys Laboratories Ltd, Hospira Worldwide, Inc, Hikma Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Beta-1 adrenergic receptor SINGLE PROTEIN AGONIST CHEMBL213
Beta-2 adrenergic receptor SINGLE PROTEIN AGONIST CHEMBL210

Unichem Links

SureChEMBL SCHEMBL21237
PharmGKB PA449381
Human Metabolome Database HMDB0014979
DrugBank DB00841
PubChem: Thomson Pharma 14825296
PubChem 36811
Mcule MCULE-6655494898
LINCS LSM-1807
Nikkaji J29.869G J399.069I
BindingDB 50325274
EPA CompTox Dashboard DTXSID3022958
DrugCentral 937
Brenda 11198 166021
ChemicalBook CB5274062
Guide to Pharmacology 535
rxnorm DOBUTAMINE DOBUTAMINE HYDROCHLORIDE
KEGG Ligand C06967
ChEBI 4670